- Home
- AOD vs SVRA Comparison
AOD vs SVRA Comparison
Compare AOD & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AOD | SVRA |
|---|---|---|
| Founded | 2006 | 2007 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AOD | SVRA |
|---|---|---|
| Price | $9.95 | $5.64 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $7.33 |
| AVG Volume (30 Days) | 423.5K | ★ 1.5M |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | ★ 12.95% | N/A |
| EPS Growth | ★ 213.63 | N/A |
| EPS | ★ 1.93 | N/A |
| Revenue | ★ $72,962,082.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.44 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.99 | $1.89 |
| 52 Week High | $9.14 | $7.01 |
Technical Indicators
Market Signals| Indicator | AOD | SVRA |
|---|---|---|
| Relative Strength Index (RSI) | 52.38 | 44.05 |
| Support Level | $9.92 | $5.60 |
| Resistance Level | $10.06 | $6.49 |
| Average True Range (ATR) | 0.11 | 0.28 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 39.51 | 13.47 |
Price Performance
Historical ComparisonAbout AOD abrdn Total Dynamic Dividend Fund of Beneficial Interest
Aberdeen Total Dynamic Dividend Fund is a diversified, closed-end management investment company. Its investment objective is to seek high current dividend income. The company also focuses on the long-term growth of capital as a secondary investment objective. The fund invests in foreign securities, including direct investments in securities of foreign issuers and investments in depositary receipts that represent indirect interests in securities of foreign issuers. Its portfolio consists of securities from Information Technology, Financial, Healthcare, and Industrials among other sectors.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.